Skip to main content

Table 1 Background and clinicopathological features of GCLS and non-GCLS patients

From: Postoperative outcomes of gastric carcinoma with lymphoid stroma

  

GCLS patients

Non-GCLS patients (control)

P value

n = 18 (%)

n = 357 (%)

 

Age (years, mean ± SD)

 

71 ± 12.3

72 ± 11.6

0.60

Gender

   

0.70

Male

14 (77.8)

263 (73.7)

 

Female

4 (22.2)

94 (16.3)

 

Surgical procedures

   

0.11

TG

10 (55.6)

108 (30.3)

 

DG

7 (38.9)

221 (61.9)

 

PG

1 (5.6)

19 (7.8)

 

Tumor diameter (mm, mean ± SD)

 

25 ± 26.9

47.2 ± 30.8

0.21

Site of tumor

   

0.003

Upper third

11 (61.1)

72 (20.2)

 

Middle third

4 (22.2)

175 (49.0)

 

Lower third

3 (16.7)

110 (30.8)

 

Number of tumors

   

0.92

Single

17 (94.4)

329 (92.2)

 

Multiple

1 (5.6)

28 (7.8)

 

Macroscopic type

   

0.44

Superficial

9 (50.0)

190 (53.2)

 

Borrmann I1 (5.6)

19 (5.3)

  

Borrmann II

4 (22.2)

52 (14.6)

 

Borrmann III

4 (22.2)

68 (19.1)

 

Borrmann IV

0 (0)

13 (3.6)

 

Borrmann V

0 (0)

15 (4.2)

 

Tumor invasion

   

0.48

T0

0 (0)

0 (0)

 

T1

11 (61.1)

184 (51.5)

 

T2

3 (16.7)

37 (10.4)

 

T3

0 (0)

70 (19.6)

 

T4

4 (22.2)

66 (18.5)

 

Number of harvested LN (mean ± SD)

 

52 ± 29.4

47.3 ± 20.5

0.53

LN metastasis

   

0.94

Absent

11 (61.1)

218 (61.1)

 

Present

7 (38.9)

139 (38.9)

 

Number of positive LN (mean ± SD)

 

1.39 ± 2.43

3.24 ± 7.8

0.01

Lymphatic invasion

   

0.33

ly0

10 (55.6)

154 (43.1)

 

ly1

2 (11.1)

114 (31.9)

 

ly2

4 (22.2)

52 (14.6)

 

ly3

2 (11.1)

37 (10.4)

 

Vascular invasion

   

0.68

v0

10 (55.6)

180 (50.4)

 

v1

5 (27.8)

100 (28.0)

 

v2

3 (16.7)

55 (15.4)

 

v3

0 (0)

22 (6.2)

 

Pathological stage

I

10 (55.5)

196 (54.9)

0.57

II

5 (27.8)

69 (19.3)

 

III

3 (17.7)

89 (24.9)

 

IV

0 (0)

3 (0.8)

 

EBV

Positive

17 (94.4)

-

 

Negative

1 (5.6)

-

 
  1. GCLS gastric carcinoma with lymphoid stroma, SD standard deviation, TG total gastrectomy, DG distal gastrectomy, PG proximal gastrectomy, LN lymph node, EBV Epstein-Barr virus